Heart MRI to predict outcomes for people getting pacemakers or defibrillators
Official title: Prognostic Value of Cardiovascular Magnetic Resonance in Patients With Cardiac Implantable Electronic Devices
Run by Chinese Academy of Medical Sciences, Fuwai Hospital · NCT07336225 · Data updated 2026-11-12
This study will try to see if detailed heart MRI scans done before device implantation can predict sudden cardiac death or similar events in adults receiving pacemakers, ICDs, or CRT.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Chinese Academy of Medical Sciences, Fuwai Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Status | Recruiting |
| Started | January 1, 2010 |
| Main results expected | December 31, 2035 |
| Study ends | December 31, 2040 |
| Registry record updated | January 27, 2026 |
| Trial ID | NCT07336225 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age 18 or older) with guideline-based indications for a pacemaker, implantable cardioverter-defibrillator, or cardiac resynchronization therapy who had preoperative CMR of diagnostic quality and available follow-up data are ideal candidates.
✕Probably not a fit
Patients with non-diagnostic or poor-quality CMR images, missing key clinical or follow-up data, prior heart transplant or ventricular assist device, or surgically corrected congenital heart disease are unlikely to benefit from inclusion in this analysis.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational cohort of adult patients who had cardiovascular magnetic resonance (CMR) imaging before consideration or implantation of a cardiac implantable electronic device (pacemaker, ICD, or CRT). Investigators will extract multiparametric CMR markers — including structural and functional indices, myocardial strain, late gadolinium enhancement, entropy, and T1/T2 mapping — from preoperative scans. Long-term clinical outcomes, with a primary endpoint of sudden cardiac death or SCD-equivalent events, will be obtained from medical records and follow-up. The goal is to determine whether these imaging markers predict adverse arrhythmic events in real-world CIED candidates.
Why it matters
Potential benefit: If successful, the approach could help clinicians better identify which device candidates are at highest risk of sudden cardiac death and tailor therapy accordingly.
How similar studies have gone: Prior research has linked CMR markers such as late gadolinium enhancement and strain to arrhythmic risk, but applying a multiparametric CMR prognostic model specifically in CIED candidates is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult patients (≥18 years old). 2. Patients with guideline-based indications for cardiac implantable electronic device (CIED) therapy, including pacemaker, implantable cardioverter-defibrillator, or cardiac resynchronization therapy. 3. Patients who underwent cardiovascular magnetic resonance (CMR) imaging as part of routine clinical evaluation prior to CIED implantation or consideration of CIED therapy. Exclusion Criteria: 1. Patients younger than 18 years of age. 2. Patients with non-diagnostic or poor-quality CMR images that preclude reliable image analysis. 3. Patients with incomplete key clinical data or missing follow-up information for primary outcome assessment. 4. Patients with prior heart transplantation or implantation of ventricular assist devices before CMR examination. 5. Patients with congenital heart disease requiring surgical correction.
Where it's running
- Beijing, China Recruiting
Study contacts
- Study coordinator: Xinqiao Lian
- Email: lxq010126@163.com
- Phone: 18810639895
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pre-discharge Flu Vaccine for patients with acute heart problems
This trial tests whether giving an influenza vaccine within 24 hours before hospital discharge helps patients who were treated for acute heart issues stay healthier this season.
-
Understanding the HeartMate 3 device and its impact on patients
This study looks at how the HeartMate 3 device affects patients with advanced heart failure by checking for problems like bleeding and infection, while also seeing how it impacts their quality of life.
-
Can fluoroscopy plus TTE guidance improve leadless pacemaker placement accuracy
This study tests whether using transthoracic echocardiography (TTE) during leadless pacemaker placement improves accuracy and safety compared with standard fluoroscopy.
-
Dual Energy ThermoCool SmartTouch SF Catheter with TRUPULSE Generator for Ventricular Arrhythmias
This study tests a special catheter and generator setup to treat ventricular arrhythmias and checks that the procedure can be done safely following a specific workflow.
-
Volta AI software in real-world AF ablation
A real-world observational study will test the latest Volta AF-Xplorer II AI software during atrial fibrillation ablation to see how safe and effective it is over 24 months.
-
Pacing decisions guided by risk for pacing-induced heart muscle weakness
This study tests a risk score to predict pacing-induced cardiomyopathy in adults getting heart rhythm devices, to tailor pacing choices.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.